How Celiac Disease Triggers an Immune Response to Gluten

When Bread Becomes the Enemy: A Genetic Predisposition

Celiac disease affects approximately 1 in 100 people worldwide, yet an estimated 83 percent of cases in the United States remain undiagnosed or misdiagnosed, according to the Celiac Disease Foundation. The average time to diagnosis stretches between 6 and 10 years. This autoimmune condition, triggered by the ingestion of gluten, a storage protein found in wheat, barley, and rye, causes the immune system to attack the lining of the small intestine.

Genetic susceptibility is a prerequisite. Virtually all celiac patients carry either the HLA-DQ2 gene (present in about 90 percent of cases) or HLA-DQ8 (most of the remainder). However, roughly 30 to 40 percent of the general population also carries these genes. Genetics loads the gun. Environmental factors pull the trigger.

The Molecular Chain Reaction Inside the Gut

Gluten proteins resist complete digestion by human enzymes. Partially digested gluten peptides, particularly a 33-amino-acid fragment from alpha-gliadin, cross the intestinal epithelial barrier. In genetically predisposed individuals, the enzyme tissue transglutaminase (tTG) modifies these peptides through a process called deamidation. This chemical alteration changes the peptide's charge, dramatically increasing its binding affinity to HLA-DQ2 or HLA-DQ8 molecules on antigen-presenting cells.

The modified peptides are then presented to CD4+ T helper cells. An aggressive immune response follows. Activated T cells release pro-inflammatory cytokines, particularly interferon-gamma, which recruit more immune cells and stimulate intraepithelial lymphocytes. These lymphocytes directly attack the intestinal epithelium. The end result is villous atrophy, the flattening of the finger-like projections that line the small intestine and absorb nutrients.

Stages of Intestinal Damage (Marsh Classification)

Symptoms That Extend Far Beyond the Gut

Classical celiac disease presents with gastrointestinal symptoms: chronic diarrhea, bloating, abdominal pain, and steatorrhea (fatty stools). Children may show failure to thrive and growth retardation. But celiac disease is a chameleon. Non-classical presentations are more common in adults and frequently delay diagnosis.

• Iron-deficiency anemia unresponsive to oral supplements
• Osteoporosis or osteopenia from calcium and vitamin D malabsorption
• Dermatitis herpetiformis: intensely itchy blistering skin rash on elbows, knees, and buttocks
• Peripheral neuropathy and cerebellar ataxia (neurological celiac disease)
• Recurrent miscarriage and unexplained infertility
• Dental enamel defects in permanent teeth
• Elevated liver enzymes without other explanation
• Depression and anxiety, more prevalent than in the general population

The damage is not limited to the duodenum. Malabsorption of fat-soluble vitamins (A, D, E, K), B12, folate, iron, and zinc produces a cascade of deficiencies. Splenic hypofunction occurs in up to 30 percent of adult celiac patients, increasing infection susceptibility.

Diagnosis: Serology First, Biopsy to Confirm

Testing must occur while the patient is still eating gluten. A gluten-free diet normalizes antibodies and heals the mucosa, potentially causing false negatives. The recommended diagnostic pathway begins with serological testing.

Esophagogastroduodenoscopy (EGD) with at least four to six biopsies from the duodenum, including the bulb, remains the gold standard for confirmation. Histology showing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes seals the diagnosis.

The Gluten-Free Diet: Only Proven Treatment

A strict, lifelong gluten-free diet is the only established treatment. Even trace amounts matter. The threshold for harm is estimated at 10 to 50 milligrams of gluten per day, equivalent to a few breadcrumbs. Foods labeled gluten-free in the United States must contain fewer than 20 parts per million.

Mucosal healing typically takes 6 to 24 months in adults, though some patients require longer. Children heal faster. Dietary adherence is monitored through follow-up tTG-IgA levels and symptom assessment. Non-responsive celiac disease, defined as persistent symptoms despite six to twelve months of a strict diet, warrants investigation for inadvertent gluten exposure, which is the most common cause.

• Hidden gluten sources: soy sauce, malt vinegar, certain medications, communion wafers
• Cross-contamination risks: shared toasters, fryers, cutting boards
• Safe grains: rice, corn, quinoa, millet, buckwheat, certified oats
• Nutritional monitoring: iron, B12, folate, vitamin D, calcium, zinc levels

Associated Conditions and Lifelong Vigilance

Celiac disease clusters with other autoimmune conditions. Type 1 diabetes co-occurs in 3 to 8 percent of celiac patients. Autoimmune thyroid disease, particularly Hashimoto's thyroiditis, affects approximately 5 to 7 percent. Other associations include Sjogren's syndrome, autoimmune hepatitis, and selective IgA deficiency.

Untreated celiac disease raises the risk of enteropathy-associated T-cell lymphoma (EATL), though this remains rare. Refractory celiac disease, where villous atrophy persists despite a strict gluten-free diet, occurs in about 1 to 2 percent of patients and requires immunosuppressive therapy. Emerging treatments under investigation include larazotide acetate, a tight junction regulator, and gluten-degrading enzymes, though none have replaced the gluten-free diet as of 2026. This article is for informational purposes only. Consult a qualified professional.